Bayesian Capital Management, LP Chroma Dex Corp. Transaction History
Bayesian Capital Management, LP
- $600 Million
- Q2 2025
A detailed history of Bayesian Capital Management, LP transactions in Chroma Dex Corp. stock. As of the latest transaction made, Bayesian Capital Management, LP holds 14,500 shares of CDXC stock, worth $89,030. This represents 0.01% of its overall portfolio holdings.
Number of Shares
14,500
Previous 13,500
7.41%
Holding current value
$89,030
Previous $93,000
4.3%
% of portfolio
0.01%
Previous 0.02%
Shares
2 transactions
Others Institutions Holding CDXC
# of Institutions
169Shares Held
27.7MCall Options Held
143KPut Options Held
189K-
Vanguard Group Inc Valley Forge, PA3.92MShares$24.1 Million0.0% of portfolio
-
Black Rock Inc. New York, NY3.12MShares$19.1 Million0.0% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY1.6MShares$9.84 Million0.01% of portfolio
-
Tieton Capital Management, LLC Yakima, WA1.58MShares$9.71 Million8.91% of portfolio
-
Geode Capital Management, LLC Boston, MA1.3MShares$7.95 Million0.0% of portfolio
About ChromaDex Corp.
- Ticker CDXC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 68,350,896
- Market Cap $420M
- Description
- ChromaDex Corporation operates as a bioscience company focusing on healthy aging. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches on nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplement products that contain its proprietary ingre...